세계의 안전 주사기 시장 : 규모 및 예측 - 제품별, 용도별, 유통 채널별, 최종사용자별, 지역별 분석(2023-2030년)

Global Safety Syringes Market is valued at approximately USD 7096.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% during the forecast period 2023-2030. Safety Syringes are specialized medical devices designed to enhance the safety of healthcare workers and patients during the administration of injections or the drawing of blood. These syringes incorporate various safety features to minimize the risk of accidental needlestick injuries and the potential transmission of bloodborne pathogens. The Safety Syringes Market is expanding because of factors such as rising demand for minimally invasive surgeries and increasing prevalence of diabetes. As a result, the demand for Safety Syringes has progressively increased in the international market during the forecast period 2023-2030.

Minimally invasive surgeries often involve multiple needle-related tasks, such as inserting catheters, delivering medications, or drawing blood and the growing demand for minimally invasive surgeries leads to increased regulatory focus on safety measures, including the use of safety syringes. Which requires healthcare facilities to implement safety protocols and adopt safety devices to minimize the risk of injuries during these procedures. According to Statista, the global minimally Invasive Surgery Market was valued at over USD 20.5 billion in 2019 and is projected to grow up to USD 44 billion by the year 2030. Furthermore, the global minimally Invasive Surgical System Market was valued at roughly USD 29 billion in 2021 and is expected to grow to more than USD 55 billion by the year 2030. Another important factor that drives the Safety Syringes Market is the increasing prevalence of diabetes. Many individuals with diabetes require insulin therapy to manage their condition. The need for frequent insulin injections increases the overall demand for safe syringes. In addition, as per the International Diabetes Federation, in 2021, 537 million adults were diagnosed with diabetes and projected to reach up to 643 million in number by 2030 and 783 million adults by the year 2045. Moreover, rising government expenditure towards healthcare infrastructure and growing awareness of infectious diseases are anticipated to create lucrative growth opportunities for the market over the forecast period. However, cost considerations and lack of regulatory standards are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Safety Syringes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high disposable income, high healthcare expenditure, and well-developed healthcare sector in the region. High disposable income in a population allows individuals and healthcare facilities to afford the costs associated with advanced medical technologies, including safe syringes. This increased affordability can lead to a higher rate of adoption among healthcare providers and facilities. The region's dominant performance is anticipated to propel the overall demand for Safety Syringes. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as supportive government initiatives towards healthcare infrastructure in the region. Government initiatives often include public health campaigns to raise awareness about the importance of safety in healthcare practices. Campaigns that emphasize the risks associated with needlestick injuries and promote the use of safe syringes contribute to increased awareness and adoption among healthcare professionals.

Major market player included in this report are:

• Becton, Dickinson and Company
• Smith's Medical, Inc.
• Cardinal Health Inc.
• DMC Medical Ltd
• Unilife Corporation
• Fresenius Kabi AG
• Kendall Healthcare Pvt. Ltd
• Retractable Technologies, Inc
• Medline Industries Lp
• Nipro Corporation

Recent Developments in the Market:

• In November 2021, Becton, Dickinson and Company, a leading global medical technology firm introduced the BD UltraSafe Plus 2.25 mL Passive Needle Guard. This innovative product is designed for utilization by pharmaceutical companies in the development of drug-device combination products. Specifically, when paired with a Glass Prefillable Syringe, the BD UltraSafe Plus 2.25 mL system facilitates the subcutaneous delivery of biologic solutions with varying fill volumes up to 2 mL and viscosities reaching up to 30 cP. The BD UltraSafe Plus 2.25 mL system addresses the requirements of healthcare providers, patients, and caregivers involved in the manual administration of biological solutions. Its distinctive design caters to the strategies of bio-pharmaceutical companies by offering patient-controlled injection options, especially beneficial for the delivery of complex, high-viscosity drugs.

Global Safety Syringes Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Application, Distribution Channel, End-user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Product

• Retractable
• Non-retractable

by Application

• Subcutaneous
• Intramuscular

by Distribution Channel

• Direct to Customer (DTC)
• Retail Sales
• Online Pharmacies

by End-user

• Hospitals
• Ambulatory Surgical Centers
• Long-term Care Facilities
• Specialty Clinics
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Safety Syringes Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Safety Syringes Market, by Product, 2020-2030 (USD Million)
  • 1.2.3. Safety Syringes Market, by Application, 2020-2030 (USD Million)
  • 1.2.4. Safety Syringes Market, by Distribution Channel, 2020-2030 (USD Million)
  • 1.2.5. Safety Syringes Market, by End-user, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Safety Syringes Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Safety Syringes Market Dynamics

• 3.1. Safety Syringes Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising demand for minimally invasive surgeries
    • 3.1.1.2. Increasing prevalence of diabetes
  • 3.1.2. Market Challenges
    • 3.1.2.1. Cost considerations
    • 3.1.2.2. Lack of regulatory standards
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising government expenditure towards healthcare infrastructure
    • 3.1.3.2. Growing awareness of infectious diseases

Chapter 4. Global Safety Syringes Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Safety Syringes Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Safety Syringes Market by Product, Performance - Potential Analysis
• 5.3. Global Safety Syringes Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4. Safety Syringes Market, Sub Segment Analysis
  • 5.4.1. Retractable
  • 5.4.2. Non-retractable

Chapter 6. Global Safety Syringes Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Safety Syringes Market by Application, Performance - Potential Analysis
• 6.3. Global Safety Syringes Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 6.4. Safety Syringes Market, Sub Segment Analysis
  • 6.4.1. Subcutaneous
  • 6.4.2. Intramuscular

Chapter 7. Global Safety Syringes Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Safety Syringes Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Safety Syringes Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
• 7.4. Safety Syringes Market, Sub Segment Analysis
  • 7.4.1. Direct to Customer (DTC)
  • 7.4.2. Retail Sales
  • 7.4.3. Online Pharmacies

Chapter 8. Global Safety Syringes Market, by End-user

• 8.1. Market Snapshot
• 8.2. Global Safety Syringes Market by End-user, Performance - Potential Analysis
• 8.3. Global Safety Syringes Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
• 8.4. Safety Syringes Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Ambulatory Surgical Centers
  • 8.4.3. Long-term Care Facilities
  • 8.4.4. Specialty Clinics
  • 8.4.5. Others

Chapter 9. Global Safety Syringes Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Safety Syringes Market, Regional Market Snapshot
• 9.4. North America Safety Syringes Market
  • 9.4.1. U.S. Safety Syringes Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Safety Syringes Market
• 9.5. Europe Safety Syringes Market Snapshot
  • 9.5.1. U.K. Safety Syringes Market
  • 9.5.2. Germany Safety Syringes Market
  • 9.5.3. France Safety Syringes Market
  • 9.5.4. Spain Safety Syringes Market
  • 9.5.5. Italy Safety Syringes Market
  • 9.5.6. Rest of Europe Safety Syringes Market
• 9.6. Asia-Pacific Safety Syringes Market Snapshot
  • 9.6.1. China Safety Syringes Market
  • 9.6.2. India Safety Syringes Market
  • 9.6.3. Japan Safety Syringes Market
  • 9.6.4. Australia Safety Syringes Market
  • 9.6.5. South Korea Safety Syringes Market
  • 9.6.6. Rest of Asia Pacific Safety Syringes Market
• 9.7. Latin America Safety Syringes Market Snapshot
  • 9.7.1. Brazil Safety Syringes Market
  • 9.7.2. Mexico Safety Syringes Market
• 9.8. Middle East & Africa Safety Syringes Market
  • 9.8.1. Saudi Arabia Safety Syringes Market
  • 9.8.2. South Africa Safety Syringes Market
  • 9.8.3. Rest of Middle East & Africa Safety Syringes Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Becton, Dickinson and Company
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Smith's Medical, Inc
  • 10.3.3. Cardinal Health Inc
  • 10.3.4. DMC Medical Ltd
  • 10.3.5. Unilife Corporation
  • 10.3.6. Fresenius Kabi AG
  • 10.3.7. Kendall Healthcare Pvt. Ltd.
  • 10.3.8. Retractable Technologies, Inc
  • 10.3.9. Medline Industries Lp
  • 10.3.10. Nipro Corporation

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption